DexTech Medical
8.40 SEK
+11.26 %
Less than 1K followers
DEX
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+11.26 %
+19.15 %
-12.50 %
+1.20 %
+110.00 %
+90.91 %
+140.00 %
-83.87 %
-13.60 %
DexTech Medical operates in biotechnology. The company conducts research and development in the field of urological oncology, where common diseases include prostate cancer. A large part of the research is carried out in collaboration with other international players, research institutes and universities. The largest operations are found in the Nordic market. The company was founded in 2004 and is headquartered in Uppsala.
Read moreMarket cap
155.28M SEK
Turnover
150.01K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
25/2
2026
Interim report Q2'26
5/5
2026
Interim report Q3'26
31/8
2026
Annual report '26
All
Press releases
ShowingAll content types
DexTech Medical's Myeloma Study (ODX-MM-001), Dose Group 2 and Dose Group 3
DexTech Medicals myelomstudie (ODX-MM-001), dosgrupp 2 och dosgrupp 3
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools